Wiggans Thomas G
SEC-identified person · CIK 1208907 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pacira Pharmaceuticals, Inc. PCRX | Director | filed 2026–2026 |
| Jasper Therapeutics, Inc. JSPR | Director | filed 2023–2025 |
| Annexon, Inc. ANNX | Director | filed 2020–2025 |
| Cymabay Therapeutics, Inc. CYMA | Director | filed 2021–2024 |
| Pardes Biosciences, INC. PRDS | Director · Chief Executive Officer | filed 2022–2023 |
| Forma Therapeutics Holdings, Inc., FTMX | Director | filed 2020–2022 |
| Dermira, Inc. DERM | Director · CEO & Chairman of the Board | filed 2014–2020 |
| Onyx Pharmaceuticals INC ONXX | Director | filed 2006–2013 |
| Somaxon Pharmaceuticals, Inc. somx | Director | filed 2008–2012 |
| Sangamo Therapeutics, INC SGMO | Director | filed 2008–2011 |
| Peplin INC PLIN | Director · CEO and Chairman of the Board | filed 2008–2009 |
| Connetics Corp CNCT | Director · Chief Executive Officer | filed 2006–2007 |
| Tercica INC TRCA | Director | filed 2006–2006 |
| Abgenix INC ABGX | Director | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.